167 related articles for article (PubMed ID: 25674263)
1. Ki-67/MIB-1 immunostaining in a cohort of human gliomas.
Skjulsvik AJ; Mørk JN; Torp MO; Torp SH
Int J Clin Exp Pathol; 2014; 7(12):8905-10. PubMed ID: 25674263
[TBL] [Abstract][Full Text] [Related]
2. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
4. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME
Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
7. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
Qu DW; Xu HS; Han XJ; Wang YL; Ouyang CJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):516-9. PubMed ID: 24610618
[TBL] [Abstract][Full Text] [Related]
9. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
10. Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.
Tanino M; Sasajima T; Nanjo H; Akesaka S; Kagaya M; Kimura T; Ishida Y; Oda M; Takahashi M; Sugawara T; Yoshioka T; Nishihara H; Akagami Y; Goto A; Minamiya Y; Tanaka S;
Brain Tumor Pathol; 2015 Jan; 32(1):12-9. PubMed ID: 24807101
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 labelling index in human brain tumours.
Niemiec J
Folia Histochem Cytobiol; 2001; 39(3):259-62. PubMed ID: 11534782
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
14. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study.
Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
Yamamoto Y; Ono Y; Aga F; Kawai N; Kudomi N; Nishiyama Y
J Nucl Med; 2012 Dec; 53(12):1911-5. PubMed ID: 23081994
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.
Eneström S; Vavruch L; Frånlund B; Nordenskjöld B
Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314
[TBL] [Abstract][Full Text] [Related]
19. Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population.
Theresia E; Malueka RG; Pranacipta S; Kameswari B; Dananjoyo K; Asmedi A; Wicaksono AS; Hartanto RA; Dwianingsih EK
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1063-1068. PubMed ID: 32334471
[TBL] [Abstract][Full Text] [Related]
20. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.
Rodríguez-Pereira C; Suárez-Peñaranda JM; Vázquez-Salvado M; Sobrido MJ; Abraldes M; Barros F; Forteza J
J Neurosurg Sci; 2000 Dec; 44(4):203-9; discussion 209-10. PubMed ID: 11327289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]